Skip to content
ANAVEX
ANAVEX
  • HOME
  • ABOUT US
  • NEWS
  • PIPELINE
  • INVESTORS
    • Events
    • Share Data
    • Analyst Coverage
    • Code of Conduct
    • Investor Material
  • JOIN US
Search
  • HOME
  • ABOUT US
  • NEWS
  • PIPELINE
  • INVESTORS
    • Events
    • Share Data
    • Analyst Coverage
    • Code of Conduct
    • Investor Material
  • JOIN US
View allAlzheimer's DiseaseAnavex2-73EventsNews ReleasesPDDPIPELINEPressRett Syndrome

Anavex CEO Invited to Present at Upcoming Investment Conferences

January 7, 2014

The Anticipated Clinical Effect of the new Alzheimer drug ANAVEX 2-73 in a Calibrated Quantitative Systems Pharmacology Platform.

December 11, 2013

Anavex Appoints Clinical Design Expert to Scientific Advisory Board

December 10, 2013

Anavex Appoints Alzheimer’s Industry Leader to Scientific Advisory Board

December 3, 2013

Anavex CEO to Participate in Brean Capital 2013 Life Sciences Summit

November 21, 2013

Anavex Announces Expansion of Scientific Advisory Board

November 20, 2013

Anavex Reports Predicted Clinical Effect for ANAVEX 2-73 in Computer Simulation Model of Alzheimer’s Disease

November 18, 2013

Anavex Announces Positive Data for ANAVEX 2-73 in Alzheimer’s Disease

November 12, 2013

Chronic treatment with the tetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic cholinergic and sigma-1 ligand, alleviates pathology in Tg2576 mice, a transgenic Alzheimer’s disease model.

November 11, 2013

Blockade of Tau Hyperphosphorylation and Ab1–42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and r1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer’s Disease.

November 11, 2013

Anavex CEO to Present Clinical Prediction Data for ANAVEX 2-73 at CNS Summit 2013

November 7, 2013

Anavex Reports ANAVEX 2-73 Blocks Tau and Amyloid-Beta Proteins in a Preclinical Model of Alzheimer’s Disease

November 4, 2013
1
234567891011121314151617181920212223
…2425262728…
2930313233343536373839404142
43

ANAVEX® is a trademark of Anavex®Life Sciences Corp. - 2019 All Rights Reserved

Go to Top